Taken together, these data support the hypothesis that late postoperative increases in GH may reflect both acquired GH resistance following RYGB, together with the reversal of obesity- and inflammation-associated reductions in GH secretion58. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.